Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients Clinical Studies, Cognition, RecruitingANAD StaffAugust 4, 2021
Evaluation of the NAD+ biosynthetic pathway in ALS patients and effect of moduating NAD+ levels in hSOD2-linked ALS mouse models Preclinical Research, CognitionANAD StaffJanuary 31, 2020
Nicotinamide riboside enhances mitochondrial proteostasis and adult neurogenesis through activationof mitochondrial unfolded protein response signaling in the brain of ALS SOD1 G93A mice Preclinical Research, CognitionANAD StaffJanuary 1, 2020
Crossover Trial for Nicotinamide Riboside in Subjective Cognitive Decline and Mild Cognitive Impairment Clinical Studies, Cognition, Not Yet RecruitingANAD StaffSeptember 4, 2019
Supplementation with nicotinamide riboside reduces brain inflammation and improves cognitive function in diabetic mice Preclinical Research, CognitionANAD StaffAugust 27, 2019
Nicotinamide ribose ameliorates cognitive impairment of aged and Alzheimer's disease model mice Preclinical, Cognition, Alzheimer'sANAD StaffDecember 6, 2018Brain Health, Alzheimer's
A Study by ChromaDex to Assess the Effects of TRU NIAGEN on Cognitive Function, Mood and Sleep in Older Adults Clinical Studies, Cognition, CompletedANAD StaffJune 19, 2018
NAD Therapy for Improving Memory and Brain Blood Flow in Older Adults With Mild Cognitive Impairment Clinical Studies, Cognition, RecruitingANAD StaffMarch 29, 2018
NAD+ supplementation normalizes key Alzheimer's features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency Preclinical Research, CognitionANAD StaffFebruary 20, 2018
Enhancing mitochondrial proteostasis reduces amyloid-beta proteotoxicity Preclinical Research, CognitionANAD StaffDecember 14, 2017
The Effects of Nicotinamide Adenine Dinucleotide (NAD) on Brain Function and Cognition Clinical Studies, Cognition, Active - Not RecruitingANAD StaffOctober 24, 2016
